Price (INR)28,235.55 Today's Change-214.65 / -0.75% Shares traded10.67k 1 Year change+9.94% Beta0.1036 Data delayed at least 15 minutes, as of Jan 14 2025 10:01 GMT. Find More Stocks Use our equities screener to discover other potential opportunities. Find Stocks Similar to ABBOTINDIAGo...
in the collapse of the deal was the decline in Abbott's stock price following the company's agreement in November to pull 125 types of medical-diagnostic test kits off the U.S. market and to pay a $100 million civil penalty to the U.S. government. Since 1993 the FDA had been issuing...
Abbott Laboratories stock price (ABT) in USD Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Abbott Laboratories stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting...
Tokyo, Publicly traded shares 33.32 Euro 126.1 35.94 Euro 145.4 Japan Knoll Pharmaceuticals Ltd., Mumbai Publicly traded shares 49.00 14.8 49.00 20.9 (Bombay), India Knoll Pharmaceuticals Ltd., Publicly traded shares 43.54 4.7 43.54 5.2 Karachi, Pakistan Knoll Colombiana S.A., Bogota Gruenenthal Co...
we always said that there was a great hedge share for us, right. And when COVID would subside, we would have a strong base business and making investments. And then I think that’s what you are seeing right now play out in these last couple of quarters and what we think is going to...
the course of the year, that will have a more positive impact. We also have gross margin improvement programs across all of our businesses that, you know, will help to offset some of those headwinds. And we're taking price where we can, I'd say, in our more consumer-facing businesses...
Abbott Laboratories is present in more than 150 countries including the USA, Brazil, Canada, the Middle East, South Africa, Europe and Asia Pacific countries like India, Singapore & China. Abbott Labs also has a sturdy manufacturing and R&D infrastructure throughout the world to cater to the la...
On April 27, 2023, Abbott completed the acquisition of Cardiovascular Systems, Inc (CSI) for $20 per common share, which equated to a purchase price of $851 million. The transaction was funded with cash on hand and accounted for as a business combination. CSI's atherectomy system, which...
in 2010 Abbott paid $6.2 billion for the pharmaceuticals unit of Belgium-based Solvay, expanding its presence in emerging markets. The same year, a plan was announced to purchase a unit of Piramal Healthcare for $3.8 billion, which would make Abbott the biggest pharmaceutical company in India....
but there’s certainly going to be a limit here in terms of what can be done. We try to match our cost hedging program and take price where appropriate. This year at current rates, our full-year headwind is a little bit more than $0.15 in terms of earnings. About 10% of that is ...